|
DNAJC24 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.799800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.245400E-01 |
| Normal-vs-Stage2 |
6.054600E-01 |
| Normal-vs-Stage3 |
8.903800E-01 |
| Normal-vs-Stage4 |
5.603400E-01 |
| Stage1-vs-Stage2 |
3.871000E-01 |
| Stage1-vs-Stage3 |
8.646600E-01 |
| Stage1-vs-Stage4 |
4.188800E-01 |
| Stage2-vs-Stage3 |
5.738600E-01 |
| Stage2-vs-Stage4 |
9.144600E-01 |
| Stage3-vs-Stage4 |
5.322200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.467200E-01 |
| Normal-vs-AfricanAmerican |
3.303200E-01 |
| Normal-vs-Asian |
6.421200E-01 |
| Caucasian-vs-AfricanAmerican |
7.854200E-02 |
| Caucasian-vs-Asian |
4.375200E-01 |
| AfricanAmerican-vs-Asian |
9.120800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.937200E-01 |
| Normal-vs-Female |
5.361800E-01 |
| Male-vs-Female |
2.276600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.295000E-01 |
| Normal-vs-Extreme_Weight |
5.704000E-01 |
| Normal-vs-Obese |
6.600000E-01 |
| Normal-vs-Extreme_Obese |
7.999400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.988200E-01 |
| Normal_Weight-vs-Obese |
5.832400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.492600E-01 |
| Extreme_Weight-vs-Obese |
3.605800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.353000E-01 |
| Obese-vs-Extreme_Obese |
7.136800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.058200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.118600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.559560E-01 |
| Normal-vs-Age(81-100Yrs) |
5.310600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.702600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.077600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.586990E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.145580E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.698200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.991200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.692000E-01 |
| Normal-VS-Type2 PRCC |
2.351600E-02 |
| Normal-VS-KIRP CIMP |
2.100400E-01 |
| Normal-VS-Unclassified PRCC |
9.152200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.119100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.916390E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.020400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.275570E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.562500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.571800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.027820E-01 |
| Normal-vs-N1 |
3.608600E-01 |
| Normal-vs-N2 |
1.542840E-01 |
| N0-vs-N1 |
4.704000E-02 |
| N0-vs-N2 |
6.925200E-01 |
| N1-vs-N2 |
2.583000E-01 |
|
|
